Alere Inc (ALR)

ALR on New York Consolidated

12 Feb 2016
Change (% chg)

$-0.07 (-0.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ALR


Alere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests... (more)


Beta: 1.33
Market Cap(Mil.): $4,549.19
Shares Outstanding(Mil.): 86.26
Dividend: --
Yield (%): --


  ALR Industry Sector
P/E (TTM): -- 354.41 37.45
EPS (TTM): -0.42 -- --
ROI: -0.47 3.13 14.17
ROE: -2.51 3.89 14.92
Search Stocks

Deals of the day-Mergers and acquisitions

Feb 1 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

01 Feb 2016

Abbott Labs to buy diagnostics company Alere for $5.8 billion

Abbott Laboratories said it would buy Alere Inc for $5.8 billion to become a leader in point-of-care testing, a fast-growing market as physicians increasingly adopt rapid tests that speed up treatment.

01 Feb 2016

REFILE-Drugmaker Abbott to buy Alere for $5.8 bln

Feb 1 Drugmaker Abbott Laboratories said it would acquire Alere Inc for $5.8 billion to boost its global diagnostics presence.

01 Feb 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
Provider : Stock Traders Daily
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks